Login / Signup

Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.

Déborah GueryLouis CousynVincent NavarroGéraldine PicardVéronique RogemondAlexandre Bani-SadrNatalia ShorBastien JoubertSergio Muñiz-CastrilloJérome HonnoratSylvain Rheims
Published in: Journal of neurology (2022)
In patients with LGI1 encephalitis, rapid initiation of immunomodulatory treatment favors long-term epilepsy remission. Evolution to DRE might primarily reflect the anatomical lesion of limbic structures. Determining what modalities of immune treatment may alter these outcomes requires prospective studies with long-term follow-up.
Keyphrases
  • prognostic factors
  • high resolution
  • mass spectrometry
  • combination therapy
  • adipose tissue
  • skeletal muscle
  • disease activity
  • weight loss
  • glycemic control